The value of metagenomic next-generation sequencing with blood samples for the diagnosis of disseminated tuberculosis
2024

Using Blood Samples to Diagnose Disseminated Tuberculosis

Sample size: 48 publication 10 minutes Evidence: moderate

Author Information

Author(s): Ma Jing, Jiang Yongfang, He Yan, Zhou Huaying

Primary Institution: Second Xiangya Hospital, Central South University, Changsha, Hunan, China

Hypothesis

The study aims to assess the clinical value of metagenomic next-generation sequencing (mNGS) of blood samples for the identification of disseminated tuberculosis (DTB).

Conclusion

The study found that mNGS of blood samples has excellent sensitivity for diagnosing disseminated tuberculosis.

Supporting Evidence

  • 28 patients were diagnosed with DTB, while 20 were confirmed as non-DTB cases.
  • 67.9% of DTB patients contained TB sequences detectable by mNGS.
  • The sensitivity of TB mNGS in blood samples was 80% for HIV-infected patients.

Takeaway

Doctors can use a special blood test to find out if someone has a serious type of tuberculosis that spreads in the body, which is really helpful for patients, especially those with HIV.

Methodology

The study enrolled 48 individuals suspected of DTB who underwent mNGS of peripheral blood and conventional microbiological tests.

Potential Biases

Potential biases from selection and referral processes due to the study being conducted in a single center.

Limitations

The sample size was relatively small, and the study did not include traditional culture for comparative analysis.

Participant Demographics

Median age was 55 years, with 60.7% male and 35.7% HIV positive.

Statistical Information

P-Value

p = 0.012

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fcimb.2024.1456119

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication